Bionovate Technologies Corp (BIIO)

Bionovate Technologies Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2021	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Accounts Payable	0.04	0.03	0.03	0.02	0.04	0.04
Accrued Expenses	0.21	0.19	0.14	0.09	-	-
Short-Term Debt	0.28	0.28	0.23	0.22	0.27	0.04
Other Current Liabilities	-	-	-	-	-	0.15
Total Current Liabilities	0.52	0.5	0.4	0.33	0.31	0.23
Total Liabilities	0.52	0.5	0.4	0.33	0.31	0.23
Common Stock	0	0	0.01	0	0	0
Additional Paid-In Capital	2.3	2.3	2.3	2.24	2.06	0.38
Retained Earnings	-2.83	-2.8	-2.7	-2.58	-2.37	-0.63
Comprehensive Income & Other	-	-	-	-	-	0.01
Shareholders' Equity	-0.52	-0.5	-0.4	-0.33	-0.31	-0.23
Total Debt	0.28	0.28	0.23	0.22	0.27	0.04
Net Cash (Debt)	-0.28	-0.28	-0.23	-0.22	-0.27	-0.04
Net Cash Per Share	-0.04	-0.04	-0.01	-1.44	-4.25	-
Filing Date Shares Outstanding	7.75	7.75	59.42	0.16	0.16	-
Total Common Shares Outstanding	7.75	7.75	59.42	0.16	0.16	-
Working Capital	-0.52	-0.5	-0.4	-0.33	-0.31	-0.23
Book Value Per Share	-0.07	-0.06	-0.01	-2.13	-1.99	-
Tangible Book Value	-0.52	-0.5	-0.4	-0.33	-0.31	-0.23
Tangible Book Value Per Share	-0.07	-0.06	-0.01	-2.13	-1.99	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.